Jessica McDermott, MD | Profiles ...

Dr. Jessica D. McDermott

Claim this profile

Rocky Mountain Regional VA Medical Center

Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
20 reported clinical trials
33 drugs studied

About Jessica D. McDermott

Education:

  • Holds a Doctoral degree in Psychology.

Experience:

  • Completed a Postdoctoral Residency at the Rocky Mountain Regional VA Medical Center, accredited by the APA-CoA.

Area of expertise

1

Lung Cancer

Jessica D. McDermott has run 6 trials for Lung Cancer. Some of their research focus areas include:

Stage II
Stage I
Stage III
2

Non-Small Cell Lung Cancer

Jessica D. McDermott has run 5 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:

Stage II
Stage I
Stage III

Affiliated Hospitals

Image of trial facility.

Rocky Mountain Regional VA Medical Center

Image of trial facility.

Colorado Research Center

Clinical Trials Jessica D. McDermott is currently running

Image of trial facility.

Blood Sample Collection

for Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.

Recruiting

1 award

N/A

9 criteria

Image of trial facility.

Drug Combinations

for Multiple Myeloma

This phase III trial compares three-drug induction regimens followed by double-or single-drug maintenance therapy for the treatment of newly diagnosed multiple myeloma in patients who are not receiving a stem cell transplant and are considered frail or intermediate-fit based on age, comorbidities, and functional status. Treatment for multiple myeloma includes initial treatment (induction) which is the first treatment a patient receives for cancer followed by ongoing treatment (maintenance) which is given after initial treatment to help keep the cancer from coming back. There are three combinations of four different drugs being studied. Bortezomib is one of the drugs that may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Lenalidomide works by helping bone marrow to produce normal blood cells and killing cancer cells. Anti-inflammatory drugs, such as dexamethasone, lower the body's immune response and are used with other drugs in the treatment of some types of cancer. Daratumumab and hyaluronidase-fihj is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Patients receive 1 of 3 combinations of these drugs for treatment to determine which combination of study drugs works better to shrink and control multiple myeloma.

Recruiting

2 awards

Phase 3

21 criteria

More about Jessica D. McDermott

Clinical Trial Related

7 years of experience running clinical trials · Led 20 trials as a Principal Investigator · 7 Active Clinical Trials

Treatments Jessica D. McDermott has experience with

  • Biospecimen Collection
  • Stereotactic Body Radiation Therapy
  • Atezolizumab
  • Lenalidomide
  • Questionnaire Administration
  • Cisplatin

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Jessica D. McDermott specialize in?

Is Jessica D. McDermott currently recruiting for clinical trials?

Are there any treatments that Jessica D. McDermott has studied deeply?

What is the best way to schedule an appointment with Jessica D. McDermott?

What is the office address of Jessica D. McDermott?

Is there any support for travel costs?